Upload

Loading icon Loading...

This video is unavailable.

Study Findings: Testosterone and Triple Negative Breast Cancer - Mayo Clinic

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like Mayo Clinic's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike Mayo Clinic's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add Mayo Clinic's video to your playlist.

Published on Mar 22, 2012

Could blocking an androgen ( testosterone) receptor lead to a new way to treat an aggressive form of breast cancer?

That's a question researchers at the Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) in Phoenix, Ariz are exploring. Preliminary results of a Mayo Clinic -- TGen collaborative study show the androgen receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).

Barbara Pockaj, M.D., a surgical oncologist at the Mayo Clinic in Arizona, discusses the study findings and the next steps in research.

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
to add this to Watch Later

Add to